Skip to main content
. 2020 Nov 26;9(2):702–708. doi: 10.1016/j.jaip.2020.11.030

Table III.

Postpandemic VIT characteristics

No. of injections in 1 d No. of patients (%)
 2 1 (1)
 3 53 (61)
 4 33 (38)
VIT dose in 1 d No. of patients (%)
 100% of the total dose 68 (78)
 60%-85% of the total dose 13 (15)
 <60% of the total dose 6 (7)
SEs to VIT No. of patients (%)
 SR 3 (3)

50% in 5 patients, 45% in 1 patient.